Your institution may have access to this item. Find your institution then sign in to continue.
Title
Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study.
Authors
Erichsen, R; Christiansen, C F; Frøslev, T; Jacobsen, J; Sørensen, H T
Abstract
There is conflicting evidence regarding bisphosphonates and atrial fibrillation (AF) risk in osteoporosis patients. However, bisphosphonates are used in much higher doses in treatment of bone metastasis and hypercalcemia, but little is known about the AF risk in cancer patients.
Publication
British journal of cancer, 2011, Vol 105, Issue 7, p881